Microbiome Science Drives Viome's Disease Prevention Push
Viome founder Momo Vuyisich credits microbiome science with his recovery from a debilitating condition, building a company on gut-health personalisation.
Scientist Momo Vuyisich, co-founder of health technology company Viome, was told by doctors that a mysterious inflammatory condition could eventually leave him unable to walk — yet, according to a report published by Entrepreneur on 23 October 2026, he attributed his recovery to changes guided by microbiome science, and subsequently built a company centred on the belief that the gut microbiome holds the key to preventing chronic disease.
Why This Matters for Gut Health Research
Vuyisich's story arrives at a moment when interest in the gut-brain connection and microbiome science is accelerating globally — including in the UK. Institutions such as King's College London and the University of Reading are among those advancing microbiome UK research, while the British Gut Project has produced one of the world's largest citizen-science datasets on gut bacteria. Despite this momentum, per Entrepreneur, Vuyisich argues that the mainstream medical establishment has been slow to incorporate microbiome insights into standard clinical care — a gap that Viome was founded to address.
Viome's Approach: Personalised Microbiome Testing
Viome's model centres on analysing an individual's gut microbiome to generate personalised dietary and supplement recommendations aimed at reducing inflammation and lowering disease risk. According to the Entrepreneur report, Vuyisich believes that most chronic illnesses — including those with serious neurological and inflammatory components — have roots in gut dysfunction. The company's central proposition is that standard diagnostic medicine treats symptoms rather than the underlying microbial imbalances that may drive disease. This aligns with a growing body of peer-reviewed research linking gut microbiome composition to conditions ranging from depression to autoimmune disorders.
What This Means for UK Readers Seeking to Improve Gut Health Naturally
For health-conscious adults in the UK, Vuyisich's experience and Viome's wider mission underline the practical relevance of efforts to improve gut health naturally — through diet, lifestyle, and, potentially, personalised microbiome testing. The NHS currently offers limited microbiome-based interventions through standard pathways, meaning many UK consumers are turning to commercial services. The British Dietetic Association encourages a fibre-rich, varied diet as a foundation for gut health, consistent with the UK Eatwell Guide.
The core takeaway from Viome's founding story, as reported by Entrepreneur, is that personalised microbiome data may offer insights that conventional diagnostics currently overlook. As NHS gut health services evolve and UK microbiome research matures, the gap between commercial innovation and clinical practice may gradually narrow — though experts continue to call for larger, peer-reviewed clinical trials to validate commercial testing claims.
You might also like
- Gut Health Tops 2026 Nutrition Trends: What the Evidence Shows
- Protein vs Fibre: Which Keeps You Fuller?
- Smart Underwear Detects Hidden Gut Gas in Lactose Study
96 Bacterial Strains. Two Shots a Day.
GOODIE is an award-winning fermented drink with 96 live bacterial strains — more than any yogurt or kombucha — never pasteurised, clinically tested, and 8 in 10 users felt less bloating within 14 days. Curious?